HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 12 August 2013

Recents CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  17 papers were listed this time. Here's a few in our areas of research interest:

Liew D, De Abreu Lourenço R, Adena M, et al. Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes. Clin Ther. 2013 Jul 26. [Epub ahead of print] PubMed PMID: 23891361.

Parthan A, Kruse M, Yurgin N, et al. Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US. Appl Health Econ Health Policy. 2013 Jul 19. [Epub ahead of print] PubMed PMID: 23868102.

Nshimyumukiza L, Duplantie J, Gagnon M, et al. Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model. Thromb J. 2013 Jul 17;11(1):14. [Epub ahead of print] PubMed PMID: 23866305.